Fidelity Investments
STOK icon

Fidelity Investments’s Stoke Therapeutics STOK Stock Holding History

Fidelity Investments’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$174M Sell
5,313,100
-70,566
-1% -$2.26M 0.01% 993
2026
Q1 		$175M Sell
5,383,666
-217,254
-4% -$7.12M 0.01% 926
2025
Q4 		$178M Sell
5,600,920
-1,264,137
-18% -$38M 0.01% 917
2025
Q3 		$161M Sell
6,865,057
-547,925
-7% -$9.39M 0.01% 943
2025
Q2 		$84.1M Buy
7,412,982
+4,871,045
+192% +$46.2M ﹤0.01% 1191
2025
Q1 		$16.9M Buy
2,541,937
+2,376,741
+1,439% +$22.2M ﹤0.01% 1735
2024
Q4 		$1.82M Sell
165,196
-157,753
-49% -$1.94M ﹤0.01% 2473
2024
Q3 		$3.97M Sell
322,949
-75,070
-19% -$1.06M ﹤0.01% 2192
2024
Q2 		$5.38M Buy
398,019
+22,538
+6% +$304K ﹤0.01% 2059
2024
Q1 		$5.07M Buy
375,481
+370,481
+7,410% +$2.24M ﹤0.01% 2078
2023
Q4 		$26.3K Buy
5,000
+1,272
+34% +$5.44K ﹤0.01% 3809
2023
Q3 		$14.7K Sell
3,728
-2,321,757
-100% -$15.3M ﹤0.01% 3963
2023
Q2 		$24.7M Buy
2,325,485
+357,274
+18% +$3.8M ﹤0.01% 1557
2023
Q1 		$16.4M Sell
1,968,211
-1,066,438
-35% -$9.62M ﹤0.01% 1696
2022
Q4 		$28M Sell
3,034,649
-147,854
-5% -$1.54M ﹤0.01% 1482
2022
Q3 		$40.9M Buy
3,182,503
+217,515
+7% +$3.47M ﹤0.01% 1327
2022
Q2 		$39.2M Buy
2,964,988
+189,406
+7% +$2.88M ﹤0.01% 1370
2022
Q1 		$58.4M Buy
2,775,582
+220,783
+9% +$4.42M ﹤0.01% 1330
2021
Q4 		$61.3M Buy
2,554,799
+101,928
+4% +$2.43M ﹤0.01% 1341
2021
Q3 		$62.4M Buy
2,452,871
+321,415
+15% +$8.96M ﹤0.01% 1320
2021
Q2 		$71.7M Sell
2,131,456
-746,113
-26% -$26.4M 0.01% 1265
2021
Q1 		$112M Sell
2,877,569
-723,406
-20% -$41.2M 0.01% 1019
2020
Q4 		$223M Buy
3,600,975
+1,659,095
+85% +$76.1M 0.02% 696
2020
Q3 		$65M Buy
1,941,880
+1,170,014
+152% +$33.4M 0.01% 1093
2020
Q2 		$18.4M Buy
771,866
+305,519
+66% +$7.25M ﹤0.01% 1584
2020
Q1 		$10.7M Sell
466,347
-88,050
-16% -$2.18M ﹤0.01% 1672
2019
Q4 		$15.7M Buy
554,397
+111,384
+25% +$2.8M ﹤0.01% 1687
2019
Q3 		$9.52M Sell
443,013
-206,987
-32% -$5.77M ﹤0.01% 1847
2019
Q2 		$19M Buy
+650,000
New +$17.5M ﹤0.01% 1639

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments's STOK Position: Q2 2026 in Review

Fidelity Investments reduced its Stoke Therapeutics (STOK) stake by 1.3% in Q2 2026, selling an estimated $2.26M and leaving 5,313,100 shares worth $174M. The position accounts for 0.01% of the portfolio, ranked #993.

Fidelity Investments first reported a position in STOK in Q2 2019 and has held it in 29 quarters since. The position peaked at $223M in Q4 2020. 198 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Fidelity Investments held 5,313,100 shares of Stoke Therapeutics worth $174M as of Q2 2026.
  • Fidelity Investments sold 70,566 Stoke Therapeutics shares in Q2 2026, an estimated $2.26M.
  • Stoke Therapeutics made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #993 holding.
  • Fidelity Investments first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 29 quarters since.
  • Fidelity Investments's Stoke Therapeutics position peaked at $223M in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.